Designed for COVID - 19 Infection

The ICCHP have developed an evidenced based Mind Body & Immune Strengthening Mindfulness Process and is making it freely available to anyone. This is designed to help patients suffering from Covid 19 and their families, who might find the process helpful in terms of encouraging stress reduction, stimulating the immune system and the body’s innate healing capabilities.There is a free audio recording available for everyone in the world to listen to online. There is a modifiable scripted process available for use by medical/healthcare practitioners worldwide.

It was developed following a randomised controlled trial (RCT) conducted in the Hainan General Hospital in Wuhan, Hubei, China from 1 January to 16 February 2020, demonstrating the Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19.

Disclaimer: ICCHP Limited accepts no liability for the use of this recording. We recommend that anyone who suffers from current panic attacks, depression, siezures or any diagnosed psychological condition does not use this recording. Please do not listen to the rcording whilst driving or operating a machinery. The listener uses this recording at your own risk.

Lui et al (2020) : Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19, Complementary Therapies in Clinical Practice, Volume 39, 101132

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19 (coronavirus disease 2019), the respiratory illness responsible for the ongoing COVID-19 pandemic. The virus previously had a provisional name, 2019 novel coronavirus (2019-nCoV), and has also been called human coronavirus 2019 (HCoV-19 or hCoV-19). First identified in the city of Wuhan, Hubei, China, the World Health Organization declared the outbreak a Public Health Emergency of International Concern on 30 January 2020, and a pandemic on 11 March 2020. SARS‑CoV‑2 is a positive-sense single-stranded RNA virus that is contagious in humans. As described by the US National Institutes of Health, it is the successor to SARS-CoV-1, the virus that caused the 2002–2004 SARS outbreak.

SARS‑CoV‑2 is a virus of the species severe acute respiratory syndrome–related coronavirus (SARSr-CoV). It is of zoonotic origins and has close genetic similarity to bat coronaviruses, suggesting it emerged from a bat-borne virus. Research is ongoing as to whether SARS‑CoV‑2 came directly from bats or indirectly through any intermediate hosts. The virus shows little genetic diversity, indicating that the spillover event introducing SARS‑CoV‑2 to humans is likely to have occurred in late 2019. (https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome_coronavirus_2)